DLQ01 / Dermaliq - LARVOL DELTA

Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men (clinicaltrials.gov) - P1/2 | N=120 | Completed | Sponsor: Dermaliq Therapeutics, Inc. | Active, not recruiting ➔ Completed | Phase classification: P1b/2a ➔ P1/2

Phase classification • Trial completion • Alopecia • Dermatology • Immunology

Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men (clinicaltrials.gov) - P1b/2a | N=120 | Active, not recruiting | Sponsor: Dermaliq Therapeutics, Inc. | Recruiting ➔ Active, not recruiting

Enrollment closed • Alopecia • Immunology

Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men (clinicaltrials.gov) - P1b/2a | N=120 | Recruiting | Sponsor: Dermaliq Therapeutics, Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • Alopecia